Industry News prev next
Sep 13 2017
Bausch + Lomb New Glaucoma Drug
Physicians from Bausch + Lomb attended the 2017 National Glaucoma Symposium and discussed the process for getting new glaucoma drugs to the market, such as their IOP-lowering eye drop Latanoprostene Bunod, which is currently in the pipeline for FDA approval. For more information about Bausch + Lomb, visit their website: Bausch + Lomb